Crizanlizumab tmca
Advanced Glioblastoma
Sheba Medical Centermonoclonal_antibodyPhase 2
—
Rating in progress
Crizanlizumab tmca in Advanced Glioblastoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active